Hirudin Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publication Month: Nov 2020 | No. of Pages: 91 Published By: 99Strategy
Single User License: US $ 2800
Corporate User License: US $ 5600

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Hirudin market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Hirudin market segmented into
Thrombosis Disease
Recombinant Hirudin

Based on the end-use, the global Hirudin market classified into
Thrombosis Disease
Tumor Disease
Others

Based on geography, the global Hirudin market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HIRUDIN INDUSTRY
2.1 Summary about Hirudin Industry
2.2 Hirudin Market Trends
2.2.1 Hirudin Production & Consumption Trends
2.2.2 Hirudin Demand Structure Trends
2.3 Hirudin Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Natural Hirudin
4.2.2 Recombinant Hirudin
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Thrombosis Disease
4.3.2 Tumor Disease
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Natural Hirudin
5.2.2 Recombinant Hirudin
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Thrombosis Disease
5.3.2 Tumor Disease
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Natural Hirudin
6.2.2 Recombinant Hirudin
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Thrombosis Disease
6.3.2 Tumor Disease
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Natural Hirudin
7.2.2 Recombinant Hirudin
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Thrombosis Disease
7.3.2 Tumor Disease
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Natural Hirudin
8.2.2 Recombinant Hirudin
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Thrombosis Disease
8.3.2 Tumor Disease
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Natural Hirudin
9.2.2 Recombinant Hirudin
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Thrombosis Disease
9.3.2 Tumor Disease
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 The Medicines Company
10.1.2 Keyken
10.1.3 Minapharm
10.1.4 Abbott
10.1.5 SALUBRIS
10.1.6 Pfizer, Inc
10.1.7 Teva Pharmaceutical Industries Ltd
10.1.8 DUOPUTAI
10.1.9 Pentapharm
10.2 Hirudin Sales Date of Major Players (2017-2020e)
10.2.1 The Medicines Company
10.2.2 Keyken
10.2.3 Minapharm
10.2.4 Abbott
10.2.5 SALUBRIS
10.2.6 Pfizer, Inc
10.2.7 Teva Pharmaceutical Industries Ltd
10.2.8 DUOPUTAI
10.2.9 Pentapharm
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

Tables and Figures

List of Table
1.Table Hirudin Product Type Overview
2.Table Hirudin Product Type Market Share List
3.Table Hirudin Product Type of Major Players
4.Table Brief Introduction of The Medicines Company
5.Table Brief Introduction of Keyken
6.Table Brief Introduction of Minapharm
7.Table Brief Introduction of Abbott
8.Table Brief Introduction of SALUBRIS
9.Table Brief Introduction of Pfizer, Inc
10.Table Brief Introduction of Teva Pharmaceutical Industries Ltd
11.Table Brief Introduction of DUOPUTAI
12.Table Brief Introduction of Pentapharm
13.Table Products & Services of The Medicines Company
14.Table Products & Services of Keyken
15.Table Products & Services of Minapharm
16.Table Products & Services of Abbott
17.Table Products & Services of SALUBRIS
18.Table Products & Services of Pfizer, Inc
19.Table Products & Services of Teva Pharmaceutical Industries Ltd
20.Table Products & Services of DUOPUTAI
21.Table Products & Services of Pentapharm
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Hirudin Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Hirudin Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Hirudin Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Hirudin Market Forecast (Million USD) Share by Demand 2021f-2026f



List Of Figures
List of Figure
1.Figure Global Hirudin Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Hirudin Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Hirudin Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Hirudin Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Hirudin Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Hirudin Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Hirudin Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Natural Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Recombinant Hirudin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Thrombosis Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Tumor Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Hirudin Sales Revenue (Million USD) of The Medicines Company 2017-2020e
66.Figure Hirudin Sales Revenue (Million USD) of Keyken 2017-2020e
67.Figure Hirudin Sales Revenue (Million USD) of Minapharm 2017-2020e
68.Figure Hirudin Sales Revenue (Million USD) of Abbott 2017-2020e
69.Figure Hirudin Sales Revenue (Million USD) of SALUBRIS 2017-2020e
70.Figure Hirudin Sales Revenue (Million USD) of Pfizer, Inc 2017-2020e
71.Figure Hirudin Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd 2017-2020e
72.Figure Hirudin Sales Revenue (Million USD) of DUOPUTAI 2017-2020e
73.Figure Hirudin Sales Revenue (Million USD) of Pentapharm 2017-2020e
74.

Reason to Buy

  • Current and future of Chemical & Material Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Chemical & Material Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets